Timber Pharmaceuticals has a total of 15 patents globally, out of which 6 have been granted. Of these 15 patents, more than 80% patents are active. United States of America is where Timber Pharmaceuticals has filed the maximum number of patents, followed by Australia and Mexico. Parallelly, United States of America seems to be the main focused R&D centre and also is the origin country of Timber Pharmaceuticals.
Timber Pharmaceuticals was founded in the year 2019. The Company operates as a biotech company. The Company develops treatments for rare skin diseases.
Do read about some of the most popular patents of Timber Pharmaceuticals which have been covered by us in this article and also you can find Timber Pharmaceuticals patents information, the worldwide patent filing activity and its patent filing trend over the years, and many other stats over Timber Pharmaceuticals patent portfolio.
How many patents does the founder and the CEO of Timber Pharmaceuticals have?
The founder Zachary Rome has 3 patents and CEO John Koconis has 0 patent.
How many patents does Timber Pharmaceuticals have?
Timber Pharmaceuticals has a total of 15 patents globally. These patents belong to 3 unique patent families. Out of 15 patents, 12 patents are active.
How Many Patents did Timber Pharmaceuticals File Every Year?
Are you wondering why there is a drop in patent filing for the last two years? It is because a patent application can take up to 18 months to get published. Certainly, it doesn’t suggest a decrease in the patent filing.
Year of Patents Filing or Grant | Timber Pharmaceuticals Applications Filed | Timber Pharmaceuticals Patents Granted |
2023 | – | 1 |
2022 | 2 | 2 |
2021 | 1 | 3 |
2020 | 1 | – |
2019 | 2 | – |
2018 | 2 | – |
2016 | 7 | – |
How many Timber Pharmaceuticals patents are Alive/Dead?
How Many Patents did Timber Pharmaceuticals File in Different Countries?
Countries in which Timber Pharmaceuticals Filed Patents
Country | Patents |
United States Of America | 3 |
Australia | 2 |
Mexico | 2 |
China | 2 |
Hong Kong (S.A.R.) | 1 |
Canada | 1 |
Brazil | 1 |
Europe | 1 |
Where are Research Centres of Timber Pharmaceuticals Patents Located?
The Research Centre for all the Timber Pharmaceuticals patents is the United States of America.
What Percentage of Timber Pharmaceuticals US Patent Applications were Granted?
Timber Pharmaceuticals (Excluding its subsidiaries) has filed 2 patent applications at USPTO so far (Excluding Design and PCT applications). Out of these 0 have been granted leading to a grant rate of 0.0%.
Below are the key stats of Timber Pharmaceuticals patent prosecution at the USPTO.
Which Law Firms Filed Most US Patents for Timber Pharmaceuticals?
Law Firm | Total Applications | Success Rate |
Wiggin And Dana Llp | 2 | 0% |
List of Timber Pharmaceuticals Patents
Timber Pharmaceuticals Patents | Title |
US11471408B2 | Isotretinoin Formulations And Uses And Methods Thereof |
US10933018B2 | Isotretinoin Formulations And Uses And Methods Thereof |
US20220362148A1 | Isotretinoin Formulations And Uses And Methods Thereof |
EP3368009A1 | Isotretinoin Formulations And Uses And Methods Thereof |
CN108348456B | Isotretinoin Preparation And Its Use And Method |
CN113577050A | Isoretinoic Acid Formulations And Uses And Methods Thereof |
AU2021206858B2 | Isotretinoin Formulations And Uses And Methods Thereof |
AU2016346203B2 | Isotretinoin Formulations And Uses And Methods Thereof |
CA3002387A1 | Isotretinoin Formulations And Uses Thereof |
HK40057065A | Isotretinoin Formulations And Uses And Methods Thereof |
MX390018B | Isotretinoin Formulations And Uses And Methods Thereof. |
MX2022001772A | Isotretinoin Formulations And Uses And Methods Thereof. |
WO2019173219A1 | Compositions And Methods For Treating Pigmentation Disorders |
WO2019173215A1 | Compositions And Methods For Treating Cutaneous Fibrosis |
BR112018008556A2 | Pharmaceutical Compositions And Methods For Treatment Ichthyosis, Congenital |
What are Timber Pharmaceuticals’ key innovation segments?
What Technologies are Covered by Timber Pharmaceuticals?
The chart below distributes patents filed by Timber Pharmaceuticals